1. Home
  2. ALT vs NBR Comparison

ALT vs NBR Comparison

Compare ALT & NBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • NBR
  • Stock Information
  • Founded
  • ALT 1997
  • NBR 1952
  • Country
  • ALT United States
  • NBR Bermuda
  • Employees
  • ALT N/A
  • NBR N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • NBR Oil & Gas Production
  • Sector
  • ALT Health Care
  • NBR Energy
  • Exchange
  • ALT Nasdaq
  • NBR Nasdaq
  • Market Cap
  • ALT 327.4M
  • NBR 617.4M
  • IPO Year
  • ALT N/A
  • NBR N/A
  • Fundamental
  • Price
  • ALT $3.59
  • NBR $41.63
  • Analyst Decision
  • ALT Strong Buy
  • NBR Hold
  • Analyst Count
  • ALT 6
  • NBR 8
  • Target Price
  • ALT $17.40
  • NBR $45.63
  • AVG Volume (30 Days)
  • ALT 2.5M
  • NBR 535.9K
  • Earning Date
  • ALT 11-11-2025
  • NBR 10-21-2025
  • Dividend Yield
  • ALT N/A
  • NBR N/A
  • EPS Growth
  • ALT N/A
  • NBR N/A
  • EPS
  • ALT N/A
  • NBR N/A
  • Revenue
  • ALT $20,000.00
  • NBR $3,030,598,000.00
  • Revenue This Year
  • ALT N/A
  • NBR $10.81
  • Revenue Next Year
  • ALT $761,880.20
  • NBR $1.79
  • P/E Ratio
  • ALT N/A
  • NBR N/A
  • Revenue Growth
  • ALT N/A
  • NBR 3.49
  • 52 Week Low
  • ALT $2.90
  • NBR $23.27
  • 52 Week High
  • ALT $11.16
  • NBR $86.10
  • Technical
  • Relative Strength Index (RSI)
  • ALT 44.54
  • NBR 64.73
  • Support Level
  • ALT $3.60
  • NBR $34.70
  • Resistance Level
  • ALT $3.82
  • NBR $44.01
  • Average True Range (ATR)
  • ALT 0.17
  • NBR 1.87
  • MACD
  • ALT 0.02
  • NBR 0.52
  • Stochastic Oscillator
  • ALT 47.52
  • NBR 75.23

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About NBR Nabors Industries Ltd.

Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.

Share on Social Networks: